Broadview Ventures
North America, Massachusetts, United States, Boston
Description
Broadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.
Investor Profile
Broadview Ventures has made 74 investments, with 6 in the past 12 months and 26% as lead.
Stage Focus
- Series A (30%)
- Seed (23%)
- Series B (18%)
- Debt Financing (16%)
- Series Unknown (8%)
- Series C (4%)
- Post Ipo Equity (1%)
Country Focus
- United States (69%)
- Switzerland (7%)
- Canada (5%)
- Ireland (4%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
- Denmark (4%)
- France (3%)
- Israel (3%)
- Finland (3%)
- United Kingdom (1%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- The Netherlands (1%)
Industry Focus
- Health Care
- Biotechnology
- Medical Device
- Therapeutics
- Medical
- Pharmaceutical
- Biopharma
- Wellness
- Clinical Trials
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
